Resumen

DIAZ GARRIDO, Drialis et al. Response to the oncospecific treatment in non-microcytic carcinomas in non-surgical stage IIIa. Acta méd. Grupo Ángeles [online]. 2017, vol.15, n.1, pp.20-24. ISSN 1870-7203.

Non-small-cell lung cancer includes the most frequent malignant tumors of the lung. A descriptive, ambispective study was carried out to evaluate the clinical and radiological evolution of 61 patients with non-surgical stage IIIA non-small-cell lung cancer, treated with polychemotherapy and/or radiotherapy in the Hospital Benéfico Jurídico in the period between January 2011 and December 2013. Male subjects (70.5%) 60 years and older (63.9%) prevailed. Oncospecific treatment significantly reduced weight loss (52.5% vs. 13.1%, p = 0.007), thoracic pain (55.7% vs. 27.9%, p = 0.015) and expectoration (31.1% vs. 18.0%, p = 0.043). After the oncospecific treatment, a progressive worsening of the functional status was found (p = 0.015). More than half of the patients (57.4%) were stable (27.8%) or with some objective antitumor response (29.6%). Nevertheless, 42.6% were in progression of the disease. Although non-surgical oncospecific treatment results in a significant improvement of some symptoms in patients with stage IIIA non-small-cell lung cancer, their functional status worsens progressively, with a low objective antitumor response.

Palabras llave : Oncospecific treatment; stage IIIA; non-small-cell lung cancer.

        · resumen en Español     · texto en Español     · Español ( pdf )